MFDS — authorised 28 August 1972
- Marketing authorisation holder: BAXTER HLTHCARE
- Status: likely_approved
🇰🇷 Efrane in South Korea
MFDS authorised Efrane on 28 August 1972
Marketing authorisation
Efrane in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in South Korea
Frequently asked questions
Is Efrane approved in South Korea?
Yes. MFDS authorised it on 28 August 1972.
Who is the marketing authorisation holder for Efrane in South Korea?
BAXTER HLTHCARE holds the South Korean marketing authorisation.